Medicamentos: Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab y Pazopanib

Deadline:10 Jul 2026, 13:00

Tender information
Spain
Type
Contract
Procedure
Open procedure
Contract type
Framework agreement
Duration
6 months
CS/CC00/1101472323/26/AM: Acuerdo marco para el suministro agregado de medicamentos Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab y Pazopanib para los centros del l'Institut Català de la Salut y centros adheridos: Hospital del Mar de Barcelona, Sant Joan de Reus-Baix Camp, Hospital de Cerdanya – AECT Agrupació Europea de Cooperació Territorial, Institut d'Assistència Sanitària i Gestió de Serveis Sanitaris
Buyer
ICS - Gerència de compres
buyer-email@mail.com
organization number

Documents

Document name
Upload date
File size
First document.pdf
1 Jan 1970, 00:001 Bytes
Second document.pdf
1 Jan 1970, 00:001 Bytes
Open for offers
17 days left
Important dates
19 Jun - Publication date
10 Jul - Deadline
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?

Mercell Logo

Feel free to reach out!

Mercell is the leading European provider of e-tendering and procurement systems, and information between buyers and suppliers in the professional market.

We appreciate your input.

© Mercell Group 2026

Terms & Conditions and Privacy Notice

Mercell Group

  • Email: post@mercell.com
  • Phone: +47 21 01 88 00
  • Address: Askekroken 11, 0277 Oslo, Norway

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.